Adaptation of Vascular Smooth Muscle Cell to Degradable Metal Stent Implantation.
Wu M, Xun M, Chen Y.
ACS Biomater Sci Eng. 2023 Jul 10;9(7):4086-4100. doi: 10.1021/acsbiomaterials.3c00637. Epub 2023 Jun 26.
Pathology of stent implantation in internal mammary artery.
Mori H, Braumann R, Torii S, Jinnouchi H, Harari E, Kutys R, Romero M, Virmani R, Finn A.
Cardiovasc Interv Ther. 2019 Jan;34(1):1-8. doi: 10.1007/s12928-017-0504-7. Epub 2017 Dec 5.
Implantation of a Coronary Stent Into the Canaliculus of a Human Cadaver: A Pilot Study.
Daigle P, Morand M, Nijhawan N.
Ophthalmic Plast Reconstr Surg. 2022 Jul-Aug 01;38(4):355-358. doi: 10.1097/IOP.0000000000002109. Epub 2022 Dec 6.
Acute myocardial infarction late following stent implantation: Incidence, mechanisms and clinical presentation.
Alexopoulos D.
Int J Cardiol. 2011 Nov 3;152(3):295-301. doi: 10.1016/j.ijcard.2011.01.017. Epub 2011 Feb 3.
Long term outcomes after bare metal stent implantation.
Harikrishnan S, Muralidharan R, Mani A, Sanjay G, Prasad S, Bijulal S, Sivasankaran S, Valaparambil AK.
Indian Heart J. 2021 Nov-Dec;73(6):740-742. doi: 10.1016/j.ihj.2021.10.004. Epub 2021 Oct 21.
Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study.
Zhang J, Zhang Q, Zhao K, Bian YJ, Liu Y, Xue YT.
Medicine (Baltimore). 2022 Nov 25;101(47):e31707. doi: 10.1097/MD.0000000000031707.
Hypoechoic Halo Imaging Findings Following Femoropopliteal Artery Stent Implantation: Risk Factors and Clinical Outcomes.
Holden A, Gouëffic Y, Gray WA, Davis EJ, Weinberg I, Jaff MR.
JACC Cardiovasc Interv. 2023 Jul 10;16(13):1654-1664. doi: 10.1016/j.jcin.2023.04.037.
Angioscopic findings after drug-eluting stent implantation.
Takano M, Mizuno K.
Herz. 2007 Jun;32(4):281-6. doi: 10.1007/s00059-007-2996-x.
Farewell to Drug-Eluting Balloons for In-Stent Restonsis?: Appropriate Technique of Drug-Eluting Balloons Implantation Matters.
Kim HS, Rhee TM.
JACC Cardiovasc Interv. 2018 May 28;11(10):992-994. doi: 10.1016/j.jcin.2018.04.002.
XEN() Gel Stent compared to PRESERFLO MicroShunt implantation for primary open-angle glaucoma: two-year results.
Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, de Crom RMPC, Roelofs LCG, Berendschot TTJM, Webers CAB, Beckers HJM.
Acta Ophthalmol. 2021 May;99(3):e433-e440. doi: 10.1111/aos.14602. Epub 2020 Sep 10.
